Breaking News Instant updates and real-time market news.

CHKP

Check Point

$109.25

2.9 (2.73%)

, EQIX

Equinix

$387.39

0.63 (0.16%)

04:55
12/11/18
12/11
04:55
12/11/18
04:55

FBN Securities to hold a bus tour

Silicon Valley Technology Bus Tour continues to travel, following the first leg of the tour, December 6-7, throughout Silicon Valley, CA on December 10-11.

CHKP

Check Point

$109.25

2.9 (2.73%)

EQIX

Equinix

$387.39

0.63 (0.16%)

FTNT

Fortinet

$74.70

3.07 (4.29%)

ZS

Zscaler

$40.56

0.17 (0.42%)

FEYE

FireEye

$19.76

0.34 (1.75%)

FSCT

ForeScout

$26.70

0.87 (3.37%)

NTNX

Nutanix

$43.17

1 (2.37%)

SPLK

Splunk

$108.55

2.85 (2.70%)

  • 11

    Dec

  • 12

    Dec

  • 13

    Dec

  • 19

    Dec

  • 19

    Dec

  • 20

    Dec

  • 09

    Jan

  • 10

    Jan

  • 15

    Jan

CHKP Check Point
$109.25

2.9 (2.73%)

10/19/18
WEDB
10/19/18
NO CHANGE
Target $140
WEDB
Outperform
Wedbush sees cybersecurity spending up 20% y/y in 2019
Wedbush analyst Daniel Ives tells investors in a research note that, based on his initial survey work, he sees cybersecurity spending up 20% y/y in 2019 vs. a 16% increase in 2018, a "very positive" data for the sector. His favorite cybersecurity stocks heading into the end of the year and into 2019 are Check Point (CHKP), Zscaler (ZS), Fortinet (FTNT), Tenable (TENB), Qualys (QLYS) and CyberArt (CYBK), and says overdue M&A could be another positive catalyst for the sector.
10/24/18
JPMS
10/24/18
NO CHANGE
JPMS
Neutral
Check Point not being rewarded despite 'clean quarter,' says JPMorgan
JPMorgan analyst Sterling Auty said Check Point shares are not being rewarded despite what he called "one of the cleanest quarters that Checkpoint has reported in the last two years" relative to expectations. He said the significant improvement in North America results is evidence that the new head of sales is having a positive impact and the company's upside in cash flow also stood out to him. The analyst, who said he would like to see the company use existing cash for M&A deals to bolster future growth, keeps a Neutral rating on Check Point shares, which are down 3% in afternoon trading.
10/25/18
BMOC
10/25/18
NO CHANGE
Target $120
BMOC
Market Perform
Check Point price target lowered to $120 from $130 at BMO Capital
BMO Capital analyst Keith Bachman lowered his price target on Check Point to $120 and kept his Market Perform rating, saying that while the company delivered "solid" Q3 results, investors likely wanted to see some upside to Q4 projections to reflect more seasonal patterns. Bachman adds that while the company's subscription revenue is growing, it is still underperforming the growth rate of its peers, and will need to improve further to offset the continued decline in other products.
12/10/18
GUGG
12/10/18
INITIATION
Target $112
GUGG
Neutral
Check Point initiated with a Neutral at Guggenheim
Guggenheim analyst Imtiaz Koujalgi started Check Point Software Technologies with a Neutral rating and $112 price target.
EQIX Equinix
$387.39

0.63 (0.16%)

12/10/18
JEFF
12/10/18
UPGRADE
Target $479
JEFF
Buy
Equinix upgraded to Buy from Hold at Jefferies
Jefferies analyst Jonathan Petersen upgraded Equinix to Buy and raised his price target for the shares to $479 from $454. The company has built a data center portfolio that should consistently deliver the strongest level of organic growth among the Data Center real estate investment trusts, Petersen tells investors in a research note. He sees Equinix's earnings growth accelerating in 2019 with dilution from acquisitions now behind the company.
11/20/18
BOFA
11/20/18
NO CHANGE
BOFA
Equinix, Knight-Swift added to US 1 List at BofA/Merrill
11/01/18
MUFG
11/01/18
NO CHANGE
Target $460
MUFG
Overweight
Equinix price target lowered to $460 from $483 at MUFG
MUFG analyst Stephen Bersey lowers his price target on Equinix to $460 to reflect the "recent broader market re-rating" but also keeps his Overweight rating after today's Q3 earnings beat. The analyst notes that the REIT performed well in the quarter, executing well "against a strong set of end markets". Bersey is also positive on the performance of Equinix's new CEO Charles Meyers, saying that his "plans to improve the company's go to market efforts and channel expansion" should help to improve its sales leverage.
12/10/18
JEFF
12/10/18
DOWNGRADE
Target $102
JEFF
Hold
CoreSite Realty downgraded to Hold from Buy at Jefferies
Jefferies analyst Jonathan Petersen downgraded CoreSite Realty (COR) to Hold and lowered his price target for the shares to $102 from $107. A lack of sellable capacity reduces the company's growth outlook for 2019 and 2020, Petersen tells investors in a research note. The analyst sees better near-term growth in Digital Realty (DLR) and Equinix (EQIX), two stocks he upgraded this morning to Buy.
FTNT Fortinet
$74.70

3.07 (4.29%)

10/23/18
JPMS
10/23/18
NO CHANGE
JPMS
Neutral
Fortinet deal makes 'a lot of sense' given ZoneFox features, says JPMorgan
JPMorgan analyst Sterling Auty said Fortinet's (FTNT) acquisition of ZoneFox makes "a lot of sense" given that the latter's machine learning threat hunting and endpoint detection and response capabilities. The plans to integrate this offering with Fortinet's endpoint security solution reminds Auty of what Palo Alto Networks (PANW) did with the acquisition of Secdo, he added. He keeps a Neutral rating on Fortinet shares.
12/10/18
GUGG
12/10/18
INITIATION
Target $72
GUGG
Neutral
Fortinet initiated with a Neutral at Guggenheim
Guggenheim analyst Imtiaz Koujalgi started Fortinet with a Neutral rating and $72 price target.
11/02/18
RBCM
11/02/18
NO CHANGE
Target $76
RBCM
Sector Perform
Fortinet price target raised to $76 from $69 at RBC Capital
RBC Capital analyst Dan Bergstrom raised his price target on Fortinet to $76 after its Q3 earnings came in better than expected on 18% product growth rate - the highest since Q2 of 2016. The analyst notes that the company is benefiting from a "favorable environment, broad based Fabric-led strength and product refresh tailwinds". Bergstrom also keeps his Sector Perform rating given the competitive nature of the firewall market and the possibility of pricing pressures impacting future results.
11/05/18
DOTC
11/05/18
UPGRADE
DOTC
Buy
Fortinet upgraded to Buy from Neutral at Dougherty
ZS Zscaler
$40.56

0.17 (0.42%)

12/10/18
GUGG
12/10/18
INITIATION
Target $40
GUGG
Neutral
Zscaler initiated with a Neutral at Guggenheim
Guggenheim analyst Imtiaz Koujalgi started Zscaler with a Neutral rating and $40 price target.
10/18/18
WEDB
10/18/18
INITIATION
WEDB
Outperform
Zscaler initiated with an Outperform at Wedbush
10/19/18
WEDB
10/19/18
INITIATION
Target $48
WEDB
Outperform
Zscaler initiated with an Outperform at Wedbush
Wedbush analyst Daniel Ives initiated Zscaler with an Outperform rating and $48 price target, telling investors in a research note that the company is a "disruptive first mover" in cloud security which has essentially created a new market in the cyber security world under an innovative product umbrella and strategic focus disrupting the competitive landscape for years to come. Ives believes Zscaler is one of the best plays in the cloud security arena, which he believes is still in the very early innings of success.
FEYE FireEye
$19.76

0.34 (1.75%)

10/31/18
JPMS
10/31/18
NO CHANGE
Target $20
JPMS
Neutral
FireEye price target raised to $20 from $17.50 at JPMorgan
JPMorgan analyst Sterling Auty raised his price target for FireEye to $20 saying all key metrics were ahead of estimates in the company's Q3. Results for the September quarter were "solid" including good contribution from U.S. federal despite government announced contract value being flattish year-over-year, Auty tells investors in a post-earnings research note. The analyst adds that while FireEye has entered a "good phase" of stable billings growth, he needs to see acceleration into double-digit growth to expect sustainable outperformance. As such, Auty keeps a Neutral rating on FireEye.
10/31/18
BARD
10/31/18
NO CHANGE
Target $23
BARD
Outperform
FireEye should be bought on strength, says Baird
Baird analyst Jonathan Ruykhaver said the bull narrative for FireEye was hardened following its Q3 results. He said he remains a buyer on the company's recent strength as he believes in management's long-term product strategy and exposure across computing landscapes. Ruykhaver reiterated his Outperform rating and raised his price target to $23 from $22 on FireEye shares.
10/31/18
PIPR
10/31/18
NO CHANGE
Target $22
PIPR
Overweight
FireEye price target raised to $22 from $20 at Piper Jaffray
Piper Jaffray analyst Andrew Nowinski raised his price target for FireEye to $22 saying the company reported another solid quarter, exceeding consensus across all key metrics, including revenue, billings and earnings. Over the last 12 months, management has successfully transformed the company and "restarted the growth engine," with billings on track to increase 10% in fiscal 2018, Nowinski tells investors in a post-earnings research note. He reiterates an Overweight rating on FireEye.
10/29/18
JPMS
10/29/18
NO CHANGE
JPMS
JPMorgan lists potential Software takeover targets after Red Hat deal
The volume of acquisitions in Software appears to be picking up with over 70 transactions announced year-to-date including last night's Red Hat (RHT) takeover by IBM (IBM), JPMorgan analyst Sterling Auty tells investors in a research note. The analyst puts the deals announced this year into three buckets: strategic, where the acquirer looks to gain a strong foothold in a new segment, vertical acquiring companies, and valuation, with acquirers going after assets with discounted valuations. Auty sees number of companies fitting those same characteristics across his coverage universe. In the strategic category, the analyst sees Okta (OKTA), Palo Alto Networks (PANW), ServiceNow (NOW), RingCentral (RNG), Aspen Technology (AZPN) and DocuSign (DOCU) as potential acquisition targets. In the vertical industry exposure category, Auty lists Guidewire (GWRE), Veeva (VEEV), Medidata (MDSO), Ellie Mae (ELLI) and Q2 Holdings (QTWO) as potential targets. And in the attractive valuation bucket, the analyst sees FireEye (FEYE), Carbon Black (CBLK), Secureworks (SCWX), Akamai (AKAM) and LogMeln (LOGM) as potential candidates to get acquired.
FSCT ForeScout
$26.70

0.87 (3.37%)

11/29/18
BREN
11/29/18
INITIATION
Target $41
BREN
Buy
ForeScout initiated with a Buy at Berenberg
Berenberg analyst Alexander Frankiewicz started ForeScout Technologies with a Buy rating and $41 price target.
09/21/18
NEED
09/21/18
INITIATION
Target $47
NEED
Buy
ForeScout initiated with a Buy at Needham
Needham analyst Alex Henderson initiated ForeScout with a Buy rating and a price target of $47, citing its ability to "best identify 30% plus more devices" than the next best service in the management/network security category. The analyst also points to the marketplace potential for the company, "including the move to the cloud, exploding IoT arena, BYOD, Industrial Security, 5G and virtualization". Henderson contends that ForeScout's market is "just coming of age" while the stock offers a low valuation of 5.2-times enterprise value to expected FY19 sales vs. 8.7-times for its higher-quality Security peers.
10/18/18
BARD
10/18/18
INITIATION
Target $42
BARD
Outperform
ForeScout initiated with an Outperform at Baird
Baird analyst Jonathan Ruykhaver last night initiated coverage of ForeScout Technologies with an Outperform rating and $42 price target. The analyst thinks the market could assign a "strategic" multiple to shares above a perpetual license peer group.
10/17/18
BARD
10/17/18
INITIATION
BARD
Outperform
ForeScout initiated with an Outperform at Baird
NTNX Nutanix
$43.17

1 (2.37%)

11/28/18
NEED
11/28/18
NO CHANGE
Target $76
NEED
Buy
Nutanix price target raised to $76 from $71 at Needham
Needham analyst Jack Andrews raised his price target on Nutanix to $76 and kept his Buy rating after its strong Q1 results that saw revenues and earnings exceed expectations. The analyst further cites the management unveiling revenue breakouts across its new categories, providing greater visibility into the company's underlying drivers of growth. Andrews contends that Nutanix's rapid product innovation and increased revenue visibility should shift the perception of its shares toward comparable companies that trade at a premium valuation.
11/29/18
BARD
11/29/18
INITIATION
Target $58
BARD
Outperform
Nutanix assumed with an Outperform at Baird
Baird analyst Jonathan Ruykhaver assumed coverage on Nutanix with an Outperform rating, citing its leadership position, its rapidly growing market, an accelerated shift to a software-only model, increased success in large accounts, and current valuation. Ruykhaver has a $58 price target on Nutanix shares.
11/28/18
STFL
11/28/18
NO CHANGE
Target $55
STFL
Buy
Nutanix price target lowered to $55 from $64 at Stifel
Stifel analyst Brad Reback said Nutanix reported "a nice start to FY19," noting its better than expected Q1 revenue and Q2 revenue guidance. While he continues to believe that secular tailwinds stemming from digital transformation, hybrid cloud adoption, and company-specific drivers should drive strong software growth in coming years, Reback lowered his price target on Nutanix shares to $55 from $64 to account for multiple compression across the group. He maintains his Buy rating on Nutanix.
11/28/18
JEFF
11/28/18
NO CHANGE
Target $48
JEFF
Hold
Nutanix price target lowered to $48 from $60 at Jefferies
Jefferies analyst John DiFucci lowered his price target for Nutanix to $48 following the company's fiscal Q1 results and keeps a Hold rating on the name. The analyst says that while the Nutanix's transition to an all-software model is moving faster than expected and results this quarter exceeded estimates, he continues to "try to decipher the model, while trying to understand the current and likely long term prospects of the company." DiFucci finds the stock fairly valued at current levels.
SPLK Splunk
$108.55

2.85 (2.70%)

11/30/18
JEFF
11/30/18
NO CHANGE
Target $137
JEFF
Buy
Splunk raised guidance by more than the Q3 beat, says Jefferies
Splunk exceeded fiscal Q3 expectations, raised fiscal 2019 by more than the beat, and raised its outlook for fiscal 2020, Jefferies analyst John DiFucci tells investors in a post-earnings research note. The analyst continues to view the company as a "unique asset" that represents one of the best ways to play the Big Data theme. Further, he believes the underlying business is likely stronger than it appears. The analyst keeps a Buy rating on Splunk with a $137 price target.
11/30/18
PIPR
11/30/18
NO CHANGE
Target $130
PIPR
Overweight
Splunk price target raised to $130 from $120 at Piper Jaffray
Piper Jaffray analyst Alex Zukin raised his price target for Splunk to $130 and reiterates an Overweight rating on the shares. The analyst says the company last night posted the quarter he was were looking for, with its largest quarterly revenue beat in five years coupled with guidance that outperformed both in the current year and for fiscal 2020. Splunk's fundamentals continue to improve and it remains a "strategic asset trading at a discounted valuation," Zukin tells investors in a post-earnings research note titled "F3Q19 Earnings: Doug E. Fresh With the Beat as King Conte Drops the Mic."
11/30/18
MUFG
11/30/18
NO CHANGE
Target $130
MUFG
Overweight
Splunk target raised to $130 on 'solid momentum' at MUFG
MUFG analyst Stephen Bersey raised his price target for Splunk to $130 from $128 saying the company's "streak of solid momentum continues." The analyst views last night's fiscal Q3 results as "strong," marked by a re-acceleration of license revenue growth to 44.3% year-over-year, the highest level of the fiscal year thus far. Splunk still has a long runway of growth ahead of it as its core business solutions continue to gain traction within the enterprise vertical and as the company continues to roll out new products and solutions, Bersey tells investors in a post-earnings research note. He reiterates an Overweight rating on the name.
12/10/18
GUGG
12/10/18
DOWNGRADE
Target $117
GUGG
Neutral
Splunk resumed with a Neutral from Buy at Guggenheim
Guggenheim analyst Imtiaz Koujalgi resumed coverage of Splunk with a Neutral rating and $117 price target. The rating is a downgrade from the firm's prior coverage of Buy. Guggenheim suspended coverage of Splunk in April of this year. Koujalgi says that while the company's fundamentals are strong, he's "looking for more clarity."

TODAY'S FREE FLY STORIES

WFC

Wells Fargo

$53.80

0.3 (0.56%)

, AAPL

Apple

$265.73

3.07 (1.17%)

10:01
11/16/19
11/16
10:01
11/16/19
10:01
Periodicals
Berkshire Hathaway inactive with record cash hoard, Barron's says »

Berkshire Hathaway…

WFC

Wells Fargo

$53.80

0.3 (0.56%)

AAPL

Apple

$265.73

3.07 (1.17%)

OXY

Occidental Petroleum

$38.94

1.18 (3.13%)

BRK.B

Berkshire Hathaway

$219.74

0.38 (0.17%)

BRK.A

Berkshire Hathaway

$329,361.11

266.11 (0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jan

DIS

Disney

$144.63

-2.56 (-1.74%)

09:43
11/16/19
11/16
09:43
11/16/19
09:43
Periodicals
Disney+ may not be able to hold onto huge number of subs, Barron's says »

While Disney's (DIS)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDT

Medtronic

$112.11

2.9 (2.66%)

09:27
11/16/19
11/16
09:27
11/16/19
09:27
Periodicals
Medtronic shares 'could rise even more,' Barron's says »

Barron's recommended…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

BR

Broadridge

$119.80

0.485 (0.41%)

09:18
11/16/19
11/16
09:18
11/16/19
09:18
Periodicals
Broadridge a defensive name that can withstand slowdown, Barron's says »

Broadridge Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCD

McDonald's

$193.95

-0.02 (-0.01%)

, MDT

Medtronic

$112.11

2.9 (2.66%)

09:07
11/16/19
11/16
09:07
11/16/19
09:07
Periodicals
Barron's suggests dividend stocks for retirement savers »

In this week's…

MCD

McDonald's

$193.95

-0.02 (-0.01%)

MDT

Medtronic

$112.11

2.9 (2.66%)

KO

Coca-Cola

$52.67

0.03 (0.06%)

PRU

Prudential

$93.61

0.82 (0.88%)

SYF

Synchrony

$37.05

0.34 (0.93%)

KEY

KeyCorp

$18.96

0.1 (0.53%)

T

AT&T

$39.49

0.53 (1.36%)

AMGN

Amgen

$220.84

2.29 (1.05%)

CSCO

Cisco

$45.10

0.18 (0.40%)

RCL

Royal Caribbean

$117.91

2.69 (2.33%)

MRK

Merck

$84.89

0.33 (0.39%)

JNJ

Johnson & Johnson

$134.97

3.99 (3.05%)

MSFT

Microsoft

$149.95

1.89 (1.28%)

JPM

JPMorgan

$129.51

0.83 (0.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 18

    Nov

  • 19

    Nov

  • 19

    Nov

  • 20

    Nov

  • 21

    Nov

  • 22

    Nov

  • 02

    Dec

  • 04

    Dec

  • 07

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 10

    Dec

  • 10

    Dec

  • 14

    Jan

  • 21

    Jan

  • 23

    Jan

  • 24

    Jan

  • 24

    Jan

  • 29

    Jan

  • 05

    Feb

  • 12

    Feb

  • 14

    Mar

AMZN

Amazon.com

$1,737.49

-17.22 (-0.98%)

, MSFT

Microsoft

$149.95

1.89 (1.28%)

08:54
11/16/19
11/16
08:54
11/16/19
08:54
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AMZN

Amazon.com

$1,737.49

-17.22 (-0.98%)

MSFT

Microsoft

$149.95

1.89 (1.28%)

AAPL

Apple

$265.73

3.07 (1.17%)

CI

Cigna

$196.08

6.41 (3.38%)

CNC

Centene

$57.57

2.91 (5.32%)

CVS

CVS Health

$74.27

1.34 (1.84%)

HUM

Humana

$335.43

17.48 (5.50%)

UNH

UnitedHealth

$269.44

13.68 (5.35%)

WCG

WellCare

$312.01

10.155 (3.36%)

HNT

Health Net

$0.00

(0.00%)

MOH

Molina Healthcare

$129.60

7.3 (5.97%)

ANTM

Anthem

$298.18

16.14 (5.72%)

HCA

HCA Healthcare

$137.98

3.51 (2.61%)

CYH

Community Health

$3.12

0.25 (8.71%)

LPNT

LifePoint

$0.00

(0.00%)

UHS

Universal Health

$144.30

3.13 (2.22%)

THC

Tenet

$30.55

1.08 (3.66%)

GM

General Motors

$36.87

0.07 (0.19%)

FCAU

Fiat Chrysler

$16.02

0.04 (0.25%)

TM

Toyota

$144.29

1.16 (0.81%)

F

Ford

$8.96

0.16 (1.82%)

HMC

Honda

$28.99

0.155 (0.54%)

VWAGY

Volkswagen

$0.00

(0.00%)

BMWYY

BMW

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 19

    Nov

  • 20

    Nov

  • 20

    Nov

  • 22

    Nov

  • 04

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 13

    Dec

  • 04

    Feb

  • 06

    Feb

MDCO

The Medicines Co.

$51.92

1.03 (2.02%)

04:55
11/16/19
11/16
04:55
11/16/19
04:55
Conference/Events
Roth Capital pharmaceuticals analysts to hold a luncheon »

Analysts host Dr. John…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

CVET

Covetrus

$14.93

1.44 (10.67%)

18:41
11/15/19
11/15
18:41
11/15/19
18:41
Hot Stocks
Covetrus CEO: We're a leader in the humanization of pets »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMCSK

Comcast

$0.00

(0.00%)

, CMCSA

Comcast

$44.54

-0.93 (-2.05%)

18:02
11/15/19
11/15
18:02
11/15/19
18:02
Hot Stocks
Viacom extends cable deal for 'The Office' through 2025 »

Viacom (VIA) announced…

CMCSK

Comcast

$0.00

(0.00%)

CMCSA

Comcast

$44.54

-0.93 (-2.05%)

VIAB

Viacom

$23.07

0.59 (2.62%)

VIA

Viacom

$26.59

1.28 (5.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

CWK

Cushman & Wakefield

$19.10

0.1 (0.53%)

17:48
11/15/19
11/15
17:48
11/15/19
17:48
Hot Stocks
Cushman & Wakefield CEO sells 84.6K share of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

LMT

Lockheed Martin

$393.52

3.305 (0.85%)

17:39
11/15/19
11/15
17:39
11/15/19
17:39
Hot Stocks
Lockheed Martin awarded maximum $3.33B Air Force contract »

Lockheed Martin has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESCA

Escalade

$10.90

-0.09 (-0.82%)

17:38
11/15/19
11/15
17:38
11/15/19
17:38
Hot Stocks
Escalade CEO Fetherman to retire »

Escalade announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CZR

Caesars

$12.96

0.1 (0.78%)

, ERI

Eldorado Resorts

$52.10

0.93 (1.82%)

17:38
11/15/19
11/15
17:38
11/15/19
17:38
Hot Stocks
Eldorado, Caesars stockholders approve Eldorado acquisition of Caesars »

Eldorado Resorts (ERI)…

CZR

Caesars

$12.96

0.1 (0.78%)

ERI

Eldorado Resorts

$52.10

0.93 (1.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

EGRX

Eagle Pharmaceuticals

$57.24

0.55 (0.97%)

17:15
11/15/19
11/15
17:15
11/15/19
17:15
Syndicate
Breaking Syndicate news story on Eagle Pharmaceuticals »

Eagle Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FN

Fabrinet

$60.82

0.84 (1.40%)

17:11
11/15/19
11/15
17:11
11/15/19
17:11
Hot Stocks
Fabrinet President Gill sells 12.9K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

TEUM

Pareteum

$0.38

-0.0209 (-5.21%)

17:05
11/15/19
11/15
17:05
11/15/19
17:05
Hot Stocks
Pareteum receives noncompliance notice from Nasdaq »

Pareteum announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HEXO

Hexo

$1.78

-0.1 (-5.32%)

17:00
11/15/19
11/15
17:00
11/15/19
17:00
Hot Stocks
Hexo was cannabis was being grown in unlicensed space at Niagara site »

HEXO Corp provided…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$220.84

2.29 (1.05%)

, CELG

Celgene

$110.02

-0.01 (-0.01%)

16:57
11/15/19
11/15
16:57
11/15/19
16:57
Hot Stocks
Bristol-Myers gets FTC clearance for Celgene acquisition »

Bristol-Myers Squibb…

AMGN

Amgen

$220.84

2.29 (1.05%)

CELG

Celgene

$110.02

-0.01 (-0.01%)

BMY

Bristol-Myers

$58.61

0.11 (0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 04

    Dec

  • 07

    Dec

  • 25

    Mar

  • 04

    Apr

RAVE

Rave Restaurant

$1.44

-0.79 (-35.43%)

16:47
11/15/19
11/15
16:47
11/15/19
16:47
Hot Stocks
BBRC Asset Management reports 6.6% passive stake in Rave Restaurant »

BBRC Asset Management …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHAP

Chaparral Energy

$0.89

-0.0521 (-5.52%)

16:46
11/15/19
11/15
16:46
11/15/19
16:46
Hot Stocks
Chaparral Energy receives continued listing standard notice from NYSE »

Chaparral Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:45
11/15/19
11/15
16:45
11/15/19
16:45
General news
Breaking General news story  »

San Francisco Federal…

16:45
11/15/19
11/15
16:45
11/15/19
16:45
General news
Breaking General news story  »

San Francisco Federal…

CI

Cigna

$196.08

6.41 (3.38%)

, CNC

Centene

$57.57

2.91 (5.32%)

16:41
11/15/19
11/15
16:41
11/15/19
16:41
On The Fly
Fly Intel: Wall Street's top stories for Friday »

Stocks closed out the…

CI

Cigna

$196.08

6.41 (3.38%)

CNC

Centene

$57.57

2.91 (5.32%)

CVS

CVS Health

$74.27

1.34 (1.84%)

HUM

Humana

$335.43

17.48 (5.50%)

UNH

UnitedHealth

$269.44

13.68 (5.35%)

WCG

WellCare

$312.01

10.155 (3.36%)

HNT

Health Net

$0.00

(0.00%)

MOH

Molina Healthcare

$129.60

7.3 (5.97%)

ANTM

Anthem

$298.18

16.14 (5.72%)

HCA

HCA Healthcare

$137.98

3.51 (2.61%)

CYH

Community Health

$3.12

0.25 (8.71%)

LPNT

LifePoint

$0.00

(0.00%)

UHS

Universal Health

$144.30

3.13 (2.22%)

NVDA

Nvidia

$204.12

-5.76 (-2.74%)

AMZN

Amazon.com

$1,739.33

-15.38 (-0.88%)

MSFT

Microsoft

$149.95

1.89 (1.28%)

UAA

Under Armour

$17.78

0.65 (3.79%)

UA

Under Armour

$15.97

0.41 (2.64%)

AMRN

Amarin

$23.99

2.5 (11.63%)

JNJ

Johnson & Johnson

$134.97

3.99 (3.05%)

GOOG

Alphabet

$1,334.01

21.82 (1.66%)

GOOGL

Alphabet Class A

$1,333.33

23.54 (1.80%)

ORCL

Oracle

$56.43

0.33 (0.59%)

RH

RH

$188.73

13.535 (7.73%)

QGEN

Qiagen

$40.56

3.255 (8.73%)

FTCH

Farfetch

$9.66

2.17 (28.97%)

THC

Tenet

$30.55

1.08 (3.66%)

TORC

resTORbio

$1.10

-6.83 (-86.13%)

ACB

Aurora Cannabis

$2.72

-0.57 (-17.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 19

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 22

    Nov

  • 04

    Dec

  • 07

    Dec

  • 09

    Dec

  • 09

    Dec

  • 13

    Dec

  • 28

    Dec

  • 06

    Jan

  • 21

    Jan

  • 06

    Feb

NYT

New York Times

$31.60

0.44 (1.41%)

16:41
11/15/19
11/15
16:41
11/15/19
16:41
Hot Stocks
New York Times CEO sells 66,000 class A common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

WEX

Wex

$200.52

4.61 (2.35%)

16:41
11/15/19
11/15
16:41
11/15/19
16:41
Hot Stocks
Wex director Morris sells 3K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.